[From EM team]
“*IPT: TEVA €900M 6Y MID TO HIGH 4%” - BBG
IPT: Mid to High 4%
FV: 4.25%A
• TEVA issuing it’s EUR 600mn 6Y tranche with an IPT of mid to high 4% yield. Using TEVA’s EUR curve and referencing 7.875% Sep31’s, we see a FV of z+195bp or yield of 4.25%A.
• As a reminder Teva is a global diversified pharma company with a leading market position in generics (10% of global market share). Teva reported reasonably good 1Q25 results earlier in the month, more importantly management stated tariffs are immaterial - see link https://mni.marketnews.com/3YM437w. Moody’s also upgraded Teva to Ba1 from Ba2 last week, citing deleveraging, strong FCF generation and prudent financial policies – see link https://mni.marketnews.com/3FbCZI8. We expect S&P and Fitch could upgrade the Teva also at some point this fiscal year.

Find more articles and bullets on these widgets:
| Date | Time | Country | Event |
| 25-Apr | 0745 | FR | Manufacturing Sentiment |
| 29-Apr | 0700 | DE | GFK Consumer Climate |
| 29-Apr | 0800 | ES | HICP (p) / GDP |
| 29-Apr | 0900 | EU | M3 / Consumer Expectations Survey |
| 29-Apr | 0900 | IT | ISTAT Confidence Indices |
| 29-Apr | 1000 | EU | Consumer Confidence, Industrial Sentiment |
| 30-Apr | 0630 | FR | GDP (p) / Consumer Spending |
| 30-Apr | 0700 | DE | Import/Export Prices / Retail Sales |
| 30-Apr | 0745 | FR | HICP (p) / PPI |
| 30-Apr | 0855 | DE | Unemployment |
| 30-Apr | 0900 | DE | GDP (p) / State level CPI |
| 30-Apr | 0900 | IT | GDP (p) |
| 30-Apr | 1000 | EU | GDP preliminary flash est. |
| 30-Apr | 1000 | IT | HICP (p) |
| 30-Apr | 1100 | IT | PPI |
| 30-Apr | 1300 | DE | HICP (p) |
JGB futures are stronger, +18 compared to settlement levels, sitting near the middle of the range after a choppy session.